Thomas J. Herzfeld Advisors, Inc. - GW PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2020$4,0000.0%410.0%0.00%
+100.0%
Q4 2019$4,0000.0%41
+28.1%
0.00%0.0%
Q3 2019$4,000
-33.3%
320.0%0.00%
-50.0%
Q2 2019$6,000
-25.0%
32
-28.9%
0.00%
-33.3%
Q1 2019$8,000
+100.0%
45
+9.8%
0.00%
+50.0%
Q4 2018$4,000
-42.9%
410.0%0.00%0.0%
Q3 2018$7,0000.0%41
-19.6%
0.00%
-33.3%
Q2 2018$7,0000.0%51
-19.0%
0.00%0.0%
Q1 2018$7,000
-12.5%
630.0%0.00%0.0%
Q4 2017$8,000
+33.3%
630.0%0.00%0.0%
Q3 2017$6,0000.0%630.0%0.00%0.0%
Q2 2017$6,000
-75.0%
63
-68.7%
0.00%
-72.7%
Q1 2017$24,000
+9.1%
2010.0%0.01%
+10.0%
Q4 2016$22,000
-35.3%
201
-20.6%
0.01%
-44.4%
Q3 2016$34,000
+41.7%
253
-1.9%
0.02%
+38.5%
Q2 2016$24,000
-20.0%
258
-37.7%
0.01%
-18.8%
Q1 2016$30,000
+42.9%
414
+34.4%
0.02%
+100.0%
Q4 2015$21,000
+16.7%
308
+55.6%
0.01%0.0%
Q3 2015$18,000
-48.6%
198
-30.5%
0.01%
-46.7%
Q2 2015$35,000
+59.1%
285
+20.3%
0.02%
+50.0%
Q1 2015$22,0002370.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders